Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Robert Page to Vasodilator Agents

This is a "connection" page, showing publications Robert Page has written about Vasodilator Agents.

 
Connection Strength
 
 
 
0.464
 
  1. Morris AA, Page RL, Baumgartner LJ, Mueller SW, MacLaren R, Fish DN, Kiser TH. Thiocyanate Accumulation in Critically Ill Patients Receiving Nitroprusside Infusions. J Intensive Care Med. 2017 Oct; 32(9):547-553.
    View in: PubMed
    Score: 0.117
  2. Paul S, Page RL. Foundations of Pharmacotherapy for Heart Failure With Reduced Ejection Fraction: Evidence Meets Practice, Part I. J Cardiovasc Nurs. 2016 Mar-Apr; 31(2):101-13.
    View in: PubMed
    Score: 0.114
  3. Page RL, Ghushchyan V, Read RA, Hartsfield CL, Koch BR, Nair KV. Comparative Effectiveness of Ranolazine Versus Traditional Therapies in Chronic Stable Angina Pectoris and Concomitant Diabetes Mellitus and Impact on Health Care Resource Utilization and Cardiac Interventions. Am J Cardiol. 2015 Nov 01; 116(9):1321-8.
    View in: PubMed
    Score: 0.110
  4. Page RL, Spurck P, Bainbridge JL, Michalek J, Quaife RA. Seizures associated with regadenoson: a case series. J Nucl Cardiol. 2012 Apr; 19(2):389-91.
    View in: PubMed
    Score: 0.087
  5. Smith ML, Joglar JA, Wasmund SL, Carlson MD, Welch PJ, Hamdan MH, Quan K, Page RL. Reflex control of sympathetic activity during simulated ventricular tachycardia in humans. Circulation. 1999 Aug 10; 100(6):628-34.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)